[1]
Rama Rao Nadendla, J. Satynarayana, and Jaya Krishna Burri, “Studies on Compatibilty of Rivaroxaban with Pharmaceutical Excipients Using DSC and FTIR Spectrophotometry”, CAPR-V4, pp. 116–134, Jun. 2022.